DIANA CHARLSON: Open Payments
NPI 1689129116 · SHERIDAN, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 40 payments from 11 companies in 2025. Trend: 2023 $407 · 2024 $315 · 2025 $796
Food & beverage: $775Education: $21
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 17 | $167 |
| AstraZeneca Pharmaceuticals LP | 9 | $156 |
| Madrigal Pharmaceuticals | 1 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $80 |
| Insulet Corporation | 1 | $72 |
| Edwards Lifesciences Corporation | 2 | $60 |
| Astellas Pharma US Inc | 2 | $51 |
| Amgen Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
Products named: MOUNJARO, REZDIFFRA, BREZTRI, CAPLYTA, Omnipod, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Veozah, AIRSUPRA.
Industry payments across WY — which companies pay providers there.
